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Materials and methods
Construction of plasmids
The En2–cre transgene was constructed from the plasmids pB9 [S1],
pKS(Sal)2 (compliments of M. Hanks), pMC12 (compliments of D.L.
Song), and pBS185. The En2 minimal promoter [S2], obtained as a
2.3 kb BamHI–SmaI fragment from pB9, was fused with the 3.0 kb
BamHI–SmaI vector backbone from pKS(Sal)2. The En2 embryonic
enhancer [S2,S3] obtained as a 2.6 kb BamHI fragment from pMC12,
was inserted into the BamHI site upstream of the En2 promoter. The
construct was completed by inserting the cre coding region with a met-
allothionein polyadenylation signal, obtained as a blunted 2.4 kb
HindIII–XhoI fragment from pBS185, into the blunted ClaI site down-
stream of the En2 promoter.
The cβ–STOP–lacZ reporter transgene consists of the following ele-
ments, in 5′ to 3′ order: (1) a 3.1 kb fragment of the chick β-actin pro-
moter including the first exon, first intron, and the 5′ untranslated
portion of the second exon; (2) a loxP site; (3) a STOP sequence
[S4] containing an inverted his3 element with a false translational
stop, and an SV40 splice donor/poly(A)-addition site; (4) a second
loxP site; (5) the lacZ coding sequence containing a nuclear localiza-
tion signal (nlacZ); (6) the 3′ untranslated region (UTR) of the mouse
protamine-1 (mPrm-1) gene, included to improve expression of the
transgene. Briefly, this construct was generated by first cloning the
SalI/BglII fragment of the plasmid pnlacF into the SmaI site of plasmid
pBSlox2, thereby placing the nlacZ coding and mPrm-1 3′ UTR
sequences downstream of tandem loxP sites separated by a
polylinker region containing XhoI, BglII and HindIII sites, in an interme-
diate plasmid called pX2Z3 (E.M., unpublished). A 1.3 kb
BamHI–HindIII fragment containing the STOP sequence from
plasmid pBS241 [S4] was then inserted between the BglII and
HindIII sites flanked by the tandem loxP sites in pX2Z3, to generate
pXSTOPXnZ. Finally, a 3.1 kb SalI–XbaI fragment from the plasmid
pβact-1 containing the chick β-actin promoter was cloned between
SalI and XbaI sites located upstream of the 5′-most loxP sites in
pXSTOPXnZ, to generate the final plasmid pβact-XSTOPX-nlacZ
(referred to in this study as cβ–STOP–lacZ). Transgenic mice were
generated by injecting the 8.2 kb SalI–Asp718 fragment from this
plasmid into zygotes. A detailed restriction map of this plasmid is
available on request.
To generate the mouse (m) β–STOP–lacZ targeting vector to insert a
(loxP-STOP-loxP-nlacZ) reporter cassette into the second exon of the
mouse β-actin locus, the following steps were performed, in brief. A
3.9 kb SalI–XhoI fragment containing the 3′ arm of the mouse β-actin
gene was cloned into SmaI-digested pUC19, to generate pUC-Act3′-
2. In parallel, a fragment containing the bacterial neomycin-resistance
gene (neor) followed by the SV40 intron and three consecutive SV40
poly(A)-addition sites [S5] was inserted between the tandem loxP sites
in the plasmid pX2Z3, to generate the intermediate pXneoXnZ. The 3′
β-actin arm, with the EcoRV site inactivated, was then transferred from
pUC-Act3′ to a position immediately downstream of the lacZ coding
sequence, to generate pXneoXnZAc3′. A fragment containing the
PGK-tk cassette fused to the 5′ arm of the mouse β-actin gene (a
1.2 kb SalI–XbaI fragment with the initiator codon deleted) was ulti-
mately inserted upstream of the 5′-most loxP site to generate the final
targeting construct. The 5′ and 3′ arms of the mouse β-actin gene were
the generous gift of Richard Behringer.
Transgenic CMV–cre transgenic mice were generated from a linearized
fragment derived from plasmid pBS185 (the generous gift of Brian
Sauer), which contains the CMV promoter-enhancer, the cre coding
sequence, and introns and the 3′ UTR from the metallothionein-I (MT-I)
gene. The position of insertion and number of transgene inserts
(30–40) in line 32-3 does not appear to be deleterious, as homozy-
gous cβ–STOP–lacZ mice appear healthy.
Screening of transgenic mice
Transgenic mice were generated [S6] and identified by Southern blot
analysis. For En2–cre mice, tail DNA was digested with EcoRI and
probed with a 683 bp BamHI–MluI cre-containing fragment from
pBS185. For cβ–STOP–lacZ mice, tail DNA was digested with EcoRV
and probed with a 1.1 kb EcoRI–EcoRV nlacZ-containing fragment from
the original transgene vector. After founders were established, genotyp-
ing was usually done by three-primer PCR. Yolk sac or tail DNA from
En2–cre (0.18 µg) or cβ–STOP–lacZ (0.06 µg) was amplified for 27
cycles (1 min at 94°C, 1 min at 62°C, 1.5 min at 72°C) on a thermal
cycler. The 5′ cre primer was 5′-CATTTCGTGATGAATGCCAC-3′, the
5′ endogenous mouse metallothionein primer (which excludes
sequence in common with the mouse metallothionein polyadenylation
site downstream of cre) was 5′-CCGTAGCTCCAGCTTCACC-3′, and
the common 3′ MT primer was 5′-ACTTGCAGTTCTTGCAGGC-3′. The
5′ lacZ primer was 5′-GGTCGCTACCATTACCAGTTG-3′, the 5′
endogenous mouse protamine-1 primer (which excludes sequences in
common with the mouse protamine-1 polyadenylation site downstream
of lacZ) was 5′-AGGTGGTGTCCCCTGCTC-3′ and the common 3′
mouse protamine-1 primer was 5′-ACGCAGGAGTTTTGATGGAC-3′.
Half of the 20 µl reaction volume was analyzed on a 2% agarose gel.
With the En2/cre primers, the wild-type allele is indicated by a 588 bp
band, whereas the En2/cre transgene produces a 668 bp band. With
the cβ–STOP–lacZ primers, wild type has a 332 bp band, whereas the
cβ–STOP–lacZ transgene produces a 349 bp band.
Detection of β-galactosidase activity
E9.5 embryos were dissected into cold phosphate-buffered saline
(PBS) and transferred as dissected into PBS on ice. When all embryos
were dissected, they were changed into cold paraformaldehyde (PFA)
4%/PBS and rocked at 4°C for 1 h. After fixation, embryos were
washed three times for 30 min with wash buffer (2 mM MgCl2, 0.02%
Nonidet-P40, 0.1 M phosphate buffer pH 7.3) once at 4°C and twice at
room temperature. Embryos were then transferred to prewarmed X-gal
solution (0.1 mg/ml X-gal/DMF, 2.12 mg/ml potassium ferrocyanide
and 1.64 mg/ml potassium ferricyanide in wash buffer) and placed at
37°C overnight. The next day, they were washed twice with PBS then
placed in 10% formalin at 4°C overnight. Embryos were then washed
twice with PBS and stored in 70% ethanol at 4°C.
E14.5 embryos to be stained were dissected into cold PBS, their
heads pinched off with forceps as far down the shoulders as possible
without taking the arms, and transferred as dissected into 50 ml PBS
on ice (≤6 heads per tube). When all embryos were dissected, they
were changed into cold PFA 4%/PBS and allowed to rock at 4°C for
4 h. Following fixation, embryo heads were either cut sagittally at the
midline with a scalpel blade and washed in PBS or were transferred
into cold 30% sucrose/PBS and allowed to sit at 4°C overnight until
they sank. Such embryo heads were dried on lens paper and mounted
in OCT. A cryostat was used to cut sagittally to midline. Three to four
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head-containing blocks were placed in 50 ml tubes and allowed to rock
in 40 ml of wash buffer at room temperature for 15 min and then in
fresh 40 ml wash buffer for 30 min. Three to four brains, cut with a
scalpel or cryostat, were then put into 15–20 ml of prewarmed X-gal
solution and allowed to stand covered at 37°C overnight. After one
PBS rinse, heads were placed in 40 ml 10% formalin for 4 h to
overnight. Heads were then rinsed with PBS and stored in 70%
ethanol at 4°C.
Adult brains were dissected out dry, cooled at 4°C for 3 min and sliced
sagittally into 2 mm slices. The slices were transferred to room temper-
ature PFA 4%/PBS and then placed on ice until all brains were fin-
ished. The brain slices were changed into fresh cold PFA 4%/PBS and
placed at 4°C for 1 h: 15 min standing, 45 min rocking. After fixation,
brains were washed three times for 30 min with wash buffer, once at
4°C and twice at room temperature. They were then changed into pre-
warmed X-gal solution and placed at 37°C overnight. The next day,
brains were washed twice with PBS then placed in 10% formalin at
4°C overnight. Brains were then washed twice with PBS and stored in
70% ethanol at 4°C.
RNA in situ hybridization
Whole-mount RNA in situ procedures were carried out according to
Conlon and Rossant [S7].
Production of targeted mice: ES cell culture, screening for
homologous recombinants and chimera production
The mβ–STOP–lacZ targeting construct was generated by homolo-
gous recombination in embryonic stem (ES) cells of the
mβ–STOP–lacZ targeting construct into the second exon of the mouse
β-actin gene [S8]. The mβ–STOP–lacZ targeting construct was
released from the plasmid by SalI digestion and then introduced into
ES cells by electroporation. The R1 ES cell line [S9] was propagated,
electroporated and selected as described by Wurst and Joyner [S8].
After positive-negative selection with G418/ganciclovir-containing
media, surviving ES cell clones were analyzed by genomic Southern
blot analysis using two external probes, a 5′ 0.37 kb EcoRV fragment
and a 3′ 0.48 kb XhoI–BamHI fragment. Genomic DNA digested with
EcoRV and probed with the 5′ probe gave a 1.4 kb wild-type and
5.3 kb mutant fragment, and probed with the 3′ probe gave a 8.2 kb
wild-type and 12.5 kb mutant band. Southern blot analysis identified 3
of 55 neomycin- and ganciclovir-resistant clones as being correctly tar-
geted. Two of the targeted lines were used to produce chimeras
through aggregration with morulae [S10]. Three chimeras from one line
were found to transmit the embryonic stem cell genotype to heterozy-
gous mice after breeding with CD1 mice, referred to as β-actinneolacZ.
Homozygous β-actinneolacZ mice were never obtained, suggesting that
disruption of the β-actin gene results in embryonic lethality. Tail or yolk-
sac DNA (~10 µg) was digested with EcoRV and run on a 1% agarose
gel. A 370 bp EcoRV–XhoI β-actin-containing fragment of the original
targeting construct was used as the hybridization probe.
To determine the potential for lacZ expression from the β-actin locus, β-
actinneolacZ mice were mated with mice carrying a CMV–cre transgene,
a different line than the one used to study the STOP–lacZ mice. From
this cross, 4 of 11 progeny were identified as carrying both the tar-
geted β-actin allele and the CMVcre construct. Two of the double
transgenics carried the β-actinlacZ allele generated by Cre-mediated
deletion of neor in most cells. One of the β-actinlacZ females was
crossed with a CD1 male and killed when the embryos reached E11.5.
Various tissues were removed from the mother and half of each adult
tissue was used for either βgal staining or northern blot analysis with a
lacZ probe. As a control for lacZ expression, tissues from a mouse car-
rying the ROSA26 gene trap insertion that expresses lacZ ubiquitously
[S11] were also analyzed. Whereas every cell type in all ROSA tissues
analyzed expressed lacZ, only the brain of the adult β-actinlacZ mouse
showed any staining, primarily limited to the cortex, granular cells of the
cerebellum and hippocampus (data not shown). Northern blot analysis
did not detect a lacZ transcript in any of the β-actinlacZ tissues whereas
a transcript was detected in all of the ROSA26 tissues (data not
shown). The fact that a lacZ transcript was not detected in the brain
tissues of the β-actinlacZ mouse in spite of βgal activity probably reflects
the differing sensitivities of the two assays. Five of the nine E11.5
embryos recovered from the β-actinlacZ mouse carried the β-actinlacZ
allele and they exhibited only scattered βgal staining in cells in the heart
and, in one embryo, also in the spinal cord (data not shown). Similar
results were obtained with embryos from the other β-actinlacZ mouse.
Targeting elsewhere in the β-actin gene might produce more robust
lacZ expression, although at least one other attempt to produce a gene
trap in the first intron did not result in ubiquitous expression [S12].
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Table S1
Percentage of animals expressing bgal in various regions of
CMV–cre;cβ–STOP–lacZ adult brains.
% βgal staining (n = 20)
Brain region + ± –
Olfactory bulbs 85 15 0
Cortex 70 30 0
Ventral telencephalon 40 30* 30
Hypothalamus 20 15† 65
Thalamus 65 35‡ 0
Hippocampus 85 5 10
Tectum 30 40§ 30
Tegmentum 25 5 70
Cerebellum 40 50¶ 10
Hindbrain 25 50II 25
+ denotes strong expression in most or all cells; ± denotes mosaic
staining; – denotes expression in no or very few cells. *Ventral
telencephalon staining is strongest in the striatum. †Only a small group
of cells express in the hypothalamus. ‡Thalamus stains most strongly
anteriorly. §Often layer-specific expression in the tectum. ¶Expression
in many animals was stronger in the posterior cerebellum. IIExpression
only in the pontine nucleus of the metencephalon.
Table S2
Percentage of animals with βgal staining in various brain regions of En2–cre;cβ–STOP–lacZ double-transgenic E14.5 embryos.
Line 3 Line 4 Line 6 Line 11 Line 22
(n = 8) (n = 8) (n = 4) (n = 8) (n = 3)
Brain region + ± – + ± – + ± – + ± – + ± –
Cortex 100 50 50 100 100 100
Ventral telencephalon 100 12 88 100 100 100
Dorsal diencephalon 100 12 88 100 100 100
Ventral diencephalon 100 12 88 100 100 100
Superior colliculus 100 100 50 50 62 38 100
Inferior colliculus 100 100 50 50 62 38 100
Tegmentum 100 50 50 50 50 12 88 100
Cerebellum 100 50 50 25 75 12 88 33 67
Metencephalon 100 62 38 25 75 100 100
+ denotes strong staining in most or all cells; ± denotes mosaic staining; – denotes no or few cells staining.
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Table S3
Percentage of animals with βgal staining in various brain regions of En2–cre;cβ–STOP–lacZ double-transgenic adults.
Brain region Line 3 Line 4 Line 6 Line 11 Line 22
(n = 4) (n = 3) (n = 5) (n = 4) (n = 4)
+ ± – + ± – + ± – + ± – + ± –
Cortex 100 67 33 100 100 100
Ventral telencephalon 100 100 100 100 100
Thalamus 100 100 100 100 100
Hypothalamus 50 50 100 100 100 100
Hippocampus 100* 100* 100* 100* 100*
Superior colliculus medial 75 25 100 20 80 100 50 50
lateral 75 25 33 67 100 100 100
Inferior colliculus medial 75 25 100 60 40 25 75 75 25
lateral 75 25 67 33 100 100 100
Tegmentum medial 100 33 67 20 80 100 50 50
lateral 100 33 67 100 100 100
Cerebellum medial 75 25 33 67† 100† 100† 100
lateral 100 100 40† 60 50 50 50 50
Hindbrain 100 100 100 100 100
+ denotes strong staining in most or all cells; ± denotes mosaic staining;
– denotes no or few cells staining. *Weak and variable staining was
observed in control reporter animals. †Expression was strongest in the
posterior cerebellum. Olfactory bulbs did not stain in all samples.
